LifeMD Declares Quarterly Dividend for Series A Preferred Stockholders

NEW YORK, Sept. 22, 2026 /CourierPR/ -- LifeMD, Inc., a leading provider of virtual primary care and pharmacy services, has announced a quarterly dividend for its 8.875% Series A Cumulative Perpetual Preferred Stock (Nasdaq: LFMDP). The dividend, amounting to $0.5546875 per share, will be distributed to the stockholders on October 15, 2026. This dividend is intended for holders of record at the close of business on October 2, 2026.

LifeMD, based in the virtual care sector, connects patients with a 50-state affiliated medical group, laboratory services, a state-of-the-art in-house pharmacy, and a U.S.-based patient care center. Together, these capabilities support care across more than 200 conditions, including primary care, men’s and women’s health, weight management, and hormone therapy.

The company's announcement comes with a cautionary note regarding forward-looking statements. These statements are subject to inherent risks, uncertainties, and changes in circumstances that are difficult to predict. Forward-looking statements are based on the company's current expectations, beliefs, and assumptions regarding future plans and strategies, projections, anticipated and unanticipated events and trends, the economy, and other future conditions. These statements are made under the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995.

The dividend payment is a significant event for the company and its preferred stockholders. It reflects the company's financial health and its commitment to rewarding its investors. The dividend amount of $0.5546875 per share is a clear indication of the company's financial stability and its ability to generate consistent returns for its shareholders.

LifeMD continues to focus on making high-quality healthcare more accessible, convenient, and affordable through its comprehensive virtual care platform. The company's commitment to patient care and innovation is reflected in its ongoing efforts to expand and improve its services. The dividend announcement is part of the company's broader strategy to enhance shareholder value and maintain its position as a leader in the virtual care industry.

The company's virtual care platform supports care across a wide range of conditions, including primary care, men’s and women’s health, weight management, and hormone therapy. This comprehensive approach ensures that patients have access to a wide array of healthcare services, making it easier for them to manage their health from the comfort of their homes.

For more detailed information on LifeMD's operations and financial performance, interested parties can refer to the company's filings with the Securities and Exchange Commission. These documents provide a comprehensive overview of the company's financial health and strategic direction.